FDA: Risk of blindness from compounded eye drugFDA warns that this compounded eye drug could lead to a disease that causes blindness.
ODs: Rulers of the Land of Presbyopia
ODs: Rulers of the Land of PresbyopiaWe often perform cataract surgery with near vision correction, using monovision or presbyopia-correcting intraocular lenses (IOLs). These folks are typically happy despite having mild residual refractive error. Something magically happens between that patient getting glasses that she “just cannot wear, at all” and getting cataract surgery. Let’s follow that patient’s path.
Perspective changes after my cataract surgery
Perspective changes after my cataract surgeryWe ODs have an inherent advantage our patients do not—we know what’s coming.
Performing cataract surgery with phaco in patients with previous implantationsThis case study presents the results and advantages of phacoemulsification, which Dr Dieter W Klass and his team applied after previous implantation of an iris-fixated phakic IOL (pIOL) (Artisan, Ophtec) for the correction of high myopia without explantation of the pIOL.
Ebola may leave retinal scarThe Ebola virus may leave a retinal scar specific to the disease, according to researchers. “The distribution of these retinal scars or lesions provides the first observational evidence that the virus enters the eye via the optic nerve to reach the retina in a similar way to West Nile virus,” said Dr Paul Steptoe of the Royal Liverpool Hospital, in a press release.
NICE recommends dexamethasone adalimumab for uveitisThe UK’s National Institute for Health and Care Excellence (NICE) has given preliminary approval to dexamethasone 0.7 mg intravitreal implant (Ozurdex, Allergan) and adalimumab (Humira, AbbVie) for sight-threatening non-infectious posterior uveitis.
ECP provides primary secondary therapy option for glaucomaFor 20 years I have effectively employed endoscopic cyclophotocoagulation (ECP) as a primary or secondary line of glaucoma treatment. ECP is a minimally invasive glaucoma surgical (MIGS) option capable of reducing IOP in the majority of patients and can potentially eliminate the need for drainage surgery, including trabeculectomy (trab) and glaucoma drainage devices (GDDs).
New technology aims to improve ease, accuracy of toric IOL surgery planningAn enhancement for a proprietary cataract/refractive surgical suite will facilitate and improve astigmatism management with toric IOLs so that surgeons can expect better patient outcomes.
When an artist loses vision
What if you examined Santa Claus?
What if you examined Santa Claus?T’was the night before Christmas, and all through the towns, not an optometrist was stirring—not even an online retailer promising glasses at low cost.